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Abstract 
A novel apatite-wollastonite/poly(lactic acid) (AW/PLA) composite structure, which matches 
cortical and cancellous bone properties has been produced and evaluated in vitro and in 
vivo.  The composites structure has been produced using an innovative combination of 3D 
printed polymer and ceramic macrostructures, thermally bonded to create a hybrid 
composite structure.  In vitro cell assays demonstrated that the AW structure alone, PLA 
structure alone, and AW/PLA composite were all biocompatible, with the AW structure 
supporting the proliferation and osteogenic differentiation of rat bone marrow stromal cells.  
Within a rat calvarial defect model the AW material showed excellent osseointegration with 
the formation of new bone, and vascularisation of the porous AW structure, both when the 
AW was implanted alone and when it was part of the AW/PLA composite structure.  
However, the AW/PLA structure showed the largest amount of the newly formed bone in 
vivo, an effect which is considered to be a result of the presence of the osteoinductive AW 
structure stimulating bone growth in the larger pores of the adjacent PLA structure.  The 
layered AW/PLA structure showed no signs of delamination in any of the in vitro or in vivo 
studies, a result which is attributed to good initial bonding between polymer and ceramic, 
slow resorption rates of the two materials, and excellent osseointegration.  It is concluded 
that macro-scale composites offer an alternative route to the fabrication of bioactive bone 
implants which can provide a match to both cortical and cancellous bone properties over 
millimetre length scales. 
  
1. Introduction 
The varying mechanical properties of bone throughout its volume means that it is difficult for 
a synthetic implant formed from a single material to match the anisotropic properties in 
different regions.  Furthermore, discrete anatomical regions such as cortical, sub-chondral 
and cancellous bone each have their own unique mechanical properties and architectures 
(Keaveny and Hayes, 1993; Li and Aspden, 1997). Ceramic-polymer composites have been 
proposed as bone implants most commonly as particulate reinforced polymer structures 
(Rezwan et al., 2006), either solid or porous.  This produces a material which has the 
strength of the polymer phase, and a slightly higher modulus than the polymer phase, which 
for most resorbable biopolymers is normally a good match to the mechanical properties of 
cancellous bone (Rezwan et al., 2006). The mechanical response of an implant can also be 
varied through design of the structure and in recent years various additive manufacturing 
techniques have been used, along with other techniques, to create macro-porous structures 
in metals, polymer and ceramic materials (Mota et al., 2015; Wang et al., 2016), again 
potentially allowing properties to be matched to different regions of bone.  However, the wide 
range of variation in properties of natural bone is such that they may be better reproduced by 
bringing together two distinct structures made from two different biomaterials.   
The aim of the study reported here was to evaluate the potential for porous ceramic-polymer 
composites in bone implants, with the different constituent parts of the composite engineered 
to have properties which equate to both cortical and cancellous bone.  The two phases of 
the composite were a macroporous poly(lactic acid) (PLA) structure, with mechanical 
properties which match those of cancellous bone (Rodrigues et al., 2016), together with 
microporous apatite-wollastonite glass-ceramic (AW), with mechanical properties which 
approach those of cortical bone (Mancuso et al., 2017). PLA and AW are both recognised 
biomaterials (Narayanan et al., 2016; Kokubo, 1991), with established methods for 
processing them to create porous structures.  The overall approach adopted was to create 
the individual structures and a macro-scale composite which combined the two structures, 
and to evaluate these in vitro and in vivo to determine the value that the approach might 
offer in terms of the design of structural composite implants. 
 
2. Materials and Methods 
2.1 Raw Materials 
AW frit and powders were produced to a formulation originally proposed by Kokubo (1991): 
weight% 4.6 MgO, 44.7 CaO, 34 SiO2, 16.2 P2O5 and 0.5 CaF2.  Maltodextrin (MD) powder 
(99.5% purity) was purchased from Oneon (Bristol, UK).  The AW and maltodextrin powders 
were separately ground and sieved, and then mixed to create a powder blend which was 55 
wt% AW powder with particle sizes in the 54-90 µm range, 15 wt% AW powder with particle 
sizes in the 0-53 µm range, and 30% MD powder with particle sizes in the 0-53 µm range. 
A 3 mm nominal diameter PLA filament (4032D, Nature Works®) with an L-lactide: D-lactide 
ratio of 98:2 and a density of 1.24 g/cm3 was the material used to create the porous polymer 
structure.   
 
2.2 Indirect 3D Printing of AW 
The indirect 3D printing processing route was to use a ZPrinter 310 Plus 3D printer (ZCorp, 
USA) to produce a green part, which was then sintered in a furnace (Carbolite, Germany).  
The manufacturing process is described in Mancuso et al. (2016).  In brief, to produce the 
green part the AW/MD powder blend was loaded into the printer, and the zb®60 clear binder 
(ZCorp) jetted to sequentially bind together layers of powder.  The ZPrinter machine settings 
were: layer thickness 0.1 mm; bleed compensation off; shell saturation level 100%; shell 
binder/volume ratio 0.215; core saturation level 100%; and core binder/volume ratio 0.107.  
The green parts created were disks of nominal diameter of 10.25 mm, and nominal heights 
of 1.13 or 2.25 mm.  The green parts were sintered according to a sintering cycle originally 
developed by Xiao et al. (2008).  From room temperature the temperature was raised at 
10ºC/min to 779ºC, the temperature was then held at 779ºC for 1 hour before the 
temperature was raised to 1150ºC at 10ºC/min, where the temperature was held constant for 
1 h, after which the disks were cooled to room temperature at the natural rate of the furnace.  
AW disks were sterilised in a steam autoclave at 121ºC for 15 mins. 
 
2.3 Fused Filament Fabrication of PLA Structures 
For the PLA structure fabrication a 2-step manufacturing route described by Rodrigues et al. 
(2016) was used. Briefly the first step consisted of printing PLA rectangular porous bars with 
a nominal length or 184 mm, nominal width of 29 mm, and nominal heights of 1 or 2 mm, using 
a Fused Filament Fabrication (FFF) machine (Ultimaker 2). Then porous discs with nominal 
diameters of 10 mm were laser cut (LS6090, HPC Laser LTD) from the printed bars, using 
laser velocity and power of 25 mm/sec and 20 Watts respectively.  The PLA structures were 
sterilised through exposure to 2.5 MRad gamma irradiation. 
 
2.4 Thermal Bonding of AW and PLA Composite Structures 
The composite structures consisted of a PLA porous disk  8 mm diameter and 1 mm thick 
thermally mounted to the surface of a AW disk, of the same diameter, and also 1 mm thick. 
The thermal bonding process consisted of preheating, bonding and quenching phases. The 
AW disks were placed on a standard laboratory hot plate set to 250ºC. After a preheating 
phase of 120 seconds a PLA disk was then positioned, as to be concentric, on the top 
surface of the AW disk. The PLA was allowed to thermally adhere to the surface of the AW 
for 5-8 seconds before being quenched in pure ethanol. The composite structures were then 
set aside to allow any ethanol remaining after quenching to evaporate.  The composite 
structures were also sterilised through exposure to 2.5 MRad gamma irradiation. 
 
2.5 Material and Structural Characterisation Techniques 
An Olympus micropublisher 5.0 RTV digital microscope, an SEM Philips XL30 ESEM-FEG 
and an Xradia VersaXRM-410 micro-CT were used to image samples. X-ray powder 
diffraction spectra were obtained from a PANalytical X'Pert Pro Multipurpose Diffractometer. 
Dimensional measurements were made using Mitutoyu digital calipers.  Total and open 
porosity levels in the AW disks were determined through weighing samples of known 
dimensions using a digital scale (KERN ABT 220-5DM) when dry, wet and submerged and 
applying Archimedes principle.  Porosity levels in the PLA structures were determined 
through weighing samples of known external dimensions and using the density of PLA to 
infer the ratio of PLA to pores. 
 
2.6 In Vitro Assays 
Bone marrow-derived stromal cells (BMSCs) were isolated from adult male Sprague–Dawley 
rats as described by Tour et al. (2014), and used at passages 3 to 5. For all the in vitro assays, 
the BMSCs were seeded in triplicate for each material into 48-well plates (Corning) on the top 
of the sample discs (10,000 cells/disc/0.5 ml culture media/well) in a humidified atmosphere 
of 5% CO2 at 37°C. The experiments were repeated twice. 
2.6.1 Cytocompatibility 
The cytocompatibility was assessed by 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide colorimetric assay (Cell Proliferation Kit I (MTT), Roche Diagnostics) or by lactate 
dehydrogenase (LDH) activity assay (CytoTox 96® Non-Radioactive Cytotoxicity Assay kit, 
Promega Co.) according to manufacturer’s instructions after 24h or 48h direct contact culture  
in alpha-minimum essential medium supplemented with 10% foetal bovine serum and 
antibiotics/antimycotics  (all from Life Technologies, Inc.). 
2.6.2 Osteogenic differentiation 
Alkaline phosphatase (ALP) activity was used as a marker for the osteogenic differentiation of 
the BMSCs in the presence of the disc samples. For the ALP assay, the normal medium was 
replaced with commercially available osteogenic medium (Osteogenic Differentiation 
BulletKit™, Lonza) containing ascorbic acid, beta-glycerophosphate, and dexamethasone. 
After 7 and 14 days of the direct contact osteogenic culture, the BMSCs were washed with 
phosphate buffer, then lysed with 0.2% Triton X-100 (Sigma-Aldrich), and sonicated. The ALP 
activity was quantified by measuring the rate of formation of p-nitrophenol (pNP) produced by 
hydrolysis of p-nitrophenylphosphate (Sigma-Aldrich) in 1M diethanolamine solution, buffered 
to pH 9.8 at 37°C for 30 min using a UV/Vis spectrometer, measuring at 405 nm (Labsystems 
Multiskan MS). The ALP activity was normalized to the cell number correlated to LDH values, 
as reported previously by Allen et al. (1994), using the CytoTox 96® Non-Radioactive 
Cytotoxicity Assay kit, Promega Co. according to the manufacturer’s instructions. The final 
ALP data were expressed as µM pNP/1000 cells. The BMSCs cultured alone on tissue culture 
plastic were used as controls. 
 
2.7 In Vivo Study 
The experiments were approved by the Stockholm South Ethical Committee in accordance 
with the policy on human care and use of laboratory animals. 
2.7.1 In Vivo Model 
Fifteen adult Sprague–Dawley male rats (~350 g) were used. The rats were kept under uniform 
conditions for a period of least one week before commencement of the experiment. Free 
access to water and standard pelleted food was provided throughout the experiment. The rats 
were randomly divided into three groups based on the biomaterials they received: PLA discs 
(n=3), AW discs (n=6), and AW/PLA discs (n=6). Before implantation, the discs were washed 
with saline solution. A critical-size calvarial defect model was used (Tour et al., 2014). The 
rats were anaesthetized by subcutaneous injection of Ketamine (Ketaminol, Intervet AB) with 
Xylazine (Rompun, Bayer HealthCare). During the surgery the rat was maintained on a heating 
pad. The rat’s head was shaved, washed with 70% ethanol solution, and afterwards an incision 
was made in the sagittal plane across the cranium. The skin and underlying tissues including 
the periosteum and temporal muscle were detached to expose the calvarial bone. An 8-mm 
full thickness circular defect was created on the left parietal region using a trephine drill with a 
sterile saline irrigation. The disc was placed into the bone defect. The incisions were closed 
with single sutures in two layers. 
 
 
2.7.2 Tissue preparation, histology and histomorphometric analysis 
The rats were euthanized by CO2 inhalation at 12 weeks after surgery. The calvarial bone was 
surgically retrieved, and histologically processed. The samples were fixed in 4% neutral-
buffered formaldehyde overnight then decalcified in 12.5% ethylenediaminetetraacetic acid, 
and embedded in paraffin; 5-µm serial sections were prepared parallel to the sagittal line and 
stained with Haematoxylin and Eosin for the assessment of the general morphology or Wright-
Giemsa for the assessment of local cellular inflammatory reaction. Two central sections from 
calvaria bone defects treated with AW or AW/PLA were assessed histomorphometrically using 
an image-analysis software (ImageJ, National Institutes of Health, USA) and the percentage 
of new bone formation was quantified. The data were statistically analyzed using the Mann-
Whitney U-test, and significance was defined as p<0.05. 
 
3. Results 
3.1 Characterisation of AW, PLA, and AW/PLA Structures 
For the sintered AW disks (Figure 1) the total porosity was measured to be 41.85% 
(standard error (s.e.), 0.94%, n=10), with 12.4% (s.e. 0.29%, n=10) of this open porosity.  
The sintered disks were approximately 8 mm diameter and 2 mm thickness.  The PLA 
“logpile” structures (Figure 2) were 60% porous.  Viewed along the cylindrical axis the 
structure had 0.62 mm (+/- 0.02) wide PLA struts, with regular gaps of 0.55 mm (+/- 0.02) 
between the struts. Images of the composite structures (Figure 3) show that the height of the 
struts in the PLA logpiles was approximately 0.5 mm, and that porosity round the 
circumference of the logpile structures was open.  The bonding method allowed the PLA to 
infiltrate into the surface of the AW plug. 
The XRD spectra for the sintered AW material indicated the presence of wollastonite and 
calcium magnesium silicate phases, together with hydroxylapatite, calcium magnesium 
phosphate and fluorapatite (Figure 4).   
 
 Figure 1. Sintered AW Part Morphology (a) Stereomicroscope image of top surface of 
sintered disk (dia. 8 mm); and (b) SEM of fracture surface showing internal structure. 
 
 
 
Figure 2. Stereomicroscope view of top of 8 mm diameter laser cut PLA plugs (a) 2 mm high, 
and (b) 1 mm high 
 
 
 
 
 
 
 Figure 3. Images of bonded PLA/AW composite disks: (a) & (b) stereomicroscope images of 
8 mm diameter composite disk, (c) SEM image of interface. 
 
 Figure 4. XRD Spectrum of Sintered Material.  Phase identification: ■ wollastonite (Ref code 
01-071-0880); + calcium magnesium silicate (01-076-0525); hydroxyapatite (01-073-1731); * 
calcium magnesium phosphate (01-087-1582); ▲ fluorapatite (01-071-0880). 
 
3.2 In Vitro Assessment 
The AW, PLA and AW/PLA discs were cyto-compatible after 24h and 48h in culture (Figure 
5a). After both 7 and 14 days of osteogenic induction BMSCs had highest ALP activity when 
seeded directly onto the AW discs compared to the PLA or AW/PLA (Figure 5b).   
 
3.3 In Vivo Assessment 
Histological assessment of the calvarial defects demonstrated that all three types of the 
scaffolds were biocompatible, being well integrated into the host tissues with minimal evidence 
of the presence of inflammatory cells (Figure 6 (a)-(c)).  For all three scaffold types the bulk of 
the implanted material was still present after 12 weeks.   
The AW/PLA implant resulted in the largest amount of the newly formed bone, in both the AW 
and PLA sides of the scaffolds (Figure 6 (e)). The newly formed bone, fibrous connective 
tissue and blood vessels were observed to penetrate into the AW structure (Figure 6 (d)). No 
new bone formation was observed in the calvaria defects treated with the PLA alone. 
 
 
 
Figure 5. In vitro rat BMSCs viability data (as % vs. seeded onto AW alone ± SD) after 24h 
and 48h culture (a), and ALP activity data (average ± SD; µM pNP/1000 cells) after 7 days 
and 14 days culture (b); * P<0.05.  
 Figure 6. Histological images stained with Haematoxylin and Eosin, illustrating the general 
morphological aspect of the calvarial defect repair. (a) – PLA alone; (b) – AW alone; (c) – 
AW/PLA; Scale bar = 1 mm; HB – host bone; defect margins indicated by arrow heads; * – 
residual AW; (d) – representative image of enlarged area of the AW; nb – new bone; bv – 
blood vessel; ct  – connective tissue; Scale bar = 100 µm; (e) Box plots (maximum, third 
quartile, median, first quartile, minimum; * P<0.05) representing the percentage of the newly 
formed bone in the calvaria defects treated with AW or AW+PLA discs. 
 
 
4. Discussion 
4.1 Properties and Structure  
The structures achieved through FFF of PLA and binder jetting/sintering of AW were 
comparable in terms of porosity and morphology to those which have been previously 
reported (Rodrigues et al, 2016; Mancuso et al, 2017).  The novel porous-porous composite 
structure created by thermally bonding the two structures together offers a unique 
combination of mechanical properties and porosity, going beyond the range of combinations 
that could be achieved from a single composite material.  The thermal bonding process that 
combines the PLA structure with the AW causes the polymer to locally melt and infiltrate into 
the bioceramic structure (Fig 3), providing mechanical adhesion through physical interlocking 
of the materials. Throughout the in vitro testing no delamination of the PLA from the AW 
structures was observed, as would be expected on the basis of the slow dissolution rates of 
these two materials.   
 
4.2 Cellular Assays and Osseointegration   
The in vitro assays indicated that, when compared to the PLA alone, the AW material alone 
best supported proliferation and osteogenic differentiation of the BMSCs.  The AW/PLA 
structure initially showed the same proliferative potential as PLA, but after 48 hours in vitro 
was similar to the AW.  Indications of osteogenic differentiation potential increased from PLA 
to PLA/AW to AW.  This correlates with the known biological responses of both the PLA and 
AW materials (Hutmacher, 2007; Narayanan, 2016; Dyson, 2007; Lee, 2015). 
The in vivo experiments broadly confirmed the in vitro results.  The AW material showed 
excellent osseointegration with the formation of new bone, and vascularisation of the porous 
AW structure, both for the AW alone and when combined with the PLA.  In the absence of AW, 
the PLA structure was well tolerated however was not osteogenic.  Interestingly, the AW/PLA 
structures showed the largest amount of the newly formed bone in vivo, and the results 
indicated that the AW and PLA structures could have acted, to some extent, synergistically: 
the presence of the osteoinductive AW structure appears to have stimulated significant bone 
growth in the larger pores of the adjacent PLA structure. The exact mechanisms for this are 
difficult to define: the AW and PLA degradation products might play an important role in tuning 
the local inflammatory reaction and stimulating osteogenic differentiation of progenitor cells 
(Williams, 1992; Middleton and Tipton, 2000). 
A key concern with layered composite structures is delamination, and no delamination was 
observed in any of the composite structures, although no loading was applied.  In fact the 
degree of osseointegration of the composite structure in Figure 6 (c) indicates delamination is 
unlikely as the structure is effectively bound together by the new bone which has grown into 
and around the structure.  Clearly the structure is only held together by new bone once that 
bone has formed, and so for immediate stability the bond between the materials needs to have 
an appropriate inherent strength. With materials which resorbed quicker or did not have the 
same degree of osseointegration it is considered that the risk of delamination would be much 
higher. 
 
4.3 Implications for Bone Implant Design  
The results offer two key observations for bone implant design based on macro-scale 
composite structures.  Firstly, that it is possible through biocomposites fabricated at a macro-
scale to develop implants which provide a match to both cortical and cancellous bone 
properties.  Secondly that to avoid delamination in such structures an appropriate choice of 
materials and structures can both avoid immediate resorption and promote osseointegration.   
The mechanical properties of the two phases of the composite are such that the composites 
could be exploited for implants to treat defects which were of a size which required 
mechanical support.  Clearly an appropriate fixation scheme would be required, but if 
properly fixed the implants could be immediately load bearing.  To improve the composite 
structures, particularly for larger implants it would be preferable to further enhance the 
osseoinductivity of the PLA structure.  This could be achieved through making the structure 
from a micro-scale composite of PLA and a bioceramic (nano- or micro- HA, for instance 
(Tayton et al; 2014), or AW) or through surface functionalisation (with collagen or gelatin for 
example; Haaparanta et al., 2014).  PLA based materials have also been shown to offer 
utility for drug release (Saini et al., 2016), and so further enhancement of bioactivity could be 
achieved through incorporating specific molecules into the polymer, with the proviso that any 
effects on the mechanical properties would have to be carefully monitored.  
 
 
 5. Conclusions 
A novel AW/PLA composite structure, which matches cortical and cancellous bone 
properties over millimetre length scales has been produced.  In vitro tests on the composite 
structure indicated proliferative and osseoinductive properties in between those of AW and 
PLA alone, but in vivo the combination of the AW and PLA structures supported significant 
new bone growth.  The use of materials which are initially effectively bonded, which do not 
resorb over short timescales, and which promote significant bone ingrowth is considered an 
effective strategy to minimise delamination of layer composites in vivo. 
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